Austin Research Analytics Group, July 2007, Pages: 80
... MEDI-545 Section 5: Appendix Disclaimer Report Licensing, The world-wide market for Psoriasis therapeutics is estimated to be valued at $1-$3 billion annually. ...
Frost & Sullivan, June 2001
365659, US Emerging Psoriasis Therapeutics Markets, Targeted Immunotherapies Define Future of the Field Psoriasis affects more than seven million people in the ...
Global Industry Analysts, Inc., July 2009, Pages: 723
... 2006, 2009 & 2015 (includes corresponding Graph/Chart) II-98 Table 14: World Recent Past, Current & Future Analysis for Psoriasis Therapeutics by Geographic ...
Frost & Sullivan, July 1998 ... and Technology Trends - Competitive Analysis and Market Share - Strategic Analysis and Forecasts of the Total European Psoriasis Therapeutic Products Market ...
Business Insights, Aug 2007, Pages: 345
... targeting proinflammatory cytokines B cell-targeted therapeutics Other therapies ... in clinical development (US) Rheumatoid arthritis Psoriasis Multiple sclerosis ...
Datamonitor, Dec 2006, Pages: 150
... Novel therapeutics expanding from rheumatology indications should consider this strategy, but ... the way for anti-TNF therapies to launch directly in psoriasis. ...
Decision Resources, Inc., Aug 2005, Pages: 17
... in clinical development for conditions such as RA, psoriasis, CD, asthma ... Development of the marketed cytokine therapeutics for additional indications is ongoing ...
Frost & Sullivan, Jan 2007 ... of Biologics by Physicians The European autoimmune diseases therapeutics market is ... including rheumatoid arthritis (RA), multiple sclerosis (MS) and psoriasis. ...
Greystone Associates, Aug 2008, Pages: 130
... Drugs in Development ---Commercial Outlook --Psoriasis ---Immune Modulators Gaining ... Product Development Issues -Autoimmune Therapeutics ? Company Profiles, ...
Datamonitor, March 2009, Pages: 185
Patient perception of disease severity drives treatment-seeking behavior in psoriasis. New therapeutic options targeting specific mechanisms are set to reshape. ...
Datamonitor, Jan 2001 ... and to target three key processes in the cascade of events that lead to psoriasis. ... drug is one of the first in a new class of potential therapeutics known as ...
Arrowhead Publishers, Oct 2006 ... to Which Injectable Technology is Applicable Table 13.3 Emerging Therapeutic Areas for ... MS Therapies Graph 5.2 2005 Sales of Leading Psoriasis Biologics Graph ...
Panel Intelligence, LLC, Dec 2000, Pages: 59
... include granulomatous diseases such as sarcoid and inflammatory diseases like psoriasis. ... of the discussion, snapshots of two targeted therapeutics, and full ...
Frost & Sullivan, May 2005 ... Estimates indicate that more than two-thirds of therapeutic mAbs are used for ... long-term conditions such as non-hodgkin?s disease, psoriasis, allergic asthma ...
Jain PharmaBiotech, Nov 2009, Pages: 272
... arterial disease Peripheral ischemic disease An eNOS mutant as therapeutic for peripheral ... for skin infections Role of NO in the treatment of psoriasis NO-based ...
